Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PF-3758309 |
Synonyms | |
Therapy Description |
PF-3758309 is a p21-activated kinase (PAK) inhibitor with activity against PAK1 and PAK4, potentially resulting in decreased tumor growth (PMID: 20439741, PMID: 23543898, PMID: 32469945, PMID: 31312349). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PF-3758309 | PAK1 Inhibitor 11 | PF-3758309 is a p21-activated kinase (PAK) inhibitor with activity against PAK1 and PAK4, potentially resulting in decreased tumor growth (PMID: 20439741, PMID: 23543898, PMID: 32469945, PMID: 31312349). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|